awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50786186-C8FAE9EC-383F-499A-9447-476F108B3158
Q50786186-C8FAE9EC-383F-499A-9447-476F108B3158
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50786186-C8FAE9EC-383F-499A-9447-476F108B3158
Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgaris.
P2860
Q50786186-C8FAE9EC-383F-499A-9447-476F108B3158
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50786186-C8FAE9EC-383F-499A-9447-476F108B3158
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0cb0270c30adce53f1362f8bd7de52a8d9c98310
P2860
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.